Researchers have discovered an enzyme which, when suppressed, promotes insulin secretion and reduces hyperglycaemia associated with Type 2 diabetes.
The enzyme, named Alpha/beta hydrolase domain-6, breaks down a signal molecule named monoacylglycerol, which is instrumental in promoting insulin secretion in the blood.
Study co-director Mark Prentki said the identification of both ABHD6 and the signal was necessary to developing better therapeutics against Type 2 diabetes.
Read more at University of Montreal